Performance of laboratories in antimicrobial susceptibility testing of MB-16-03
Antibiotics | MIC | Antibiotics | Disk | ||||||
---|---|---|---|---|---|---|---|---|---|
S | I | R | IND | S | I | R | IND | ||
CLSI group A | |||||||||
Ampicillin | 213 | Ampicillin | 21 | 1 | 1 | ||||
Penicillin G | 203 | 2 | Penicillin G | 21 | 2 | ||||
Other CLSI groups | |||||||||
Chloramphenicol | 1 | Chloramphenicol | 2 | ||||||
Daptomycin | 48 | Erythromycin | 3 | 11 | 2 | ||||
Erythromycin | 61 | 2 | Gentamicin-high | 4 | |||||
Gentamicin-high | 141 | 1 | Linezolid | 3 | 1 | 1 | |||
Linezolid | 197 | 14 | 1 | Minocycline | 1 | ||||
Quinupristin/Dalfopristin | 36 | Quinupristin/Dalfopristin | 1 | ||||||
Rifampicin | 3 | Rifampin | 2 | ||||||
Rifampin | 14 | Streptomycin-high | 3 | ||||||
Streptomycin-high | 137 | 2 | Teicoplanin | 8 | 1 | 1 | |||
Teicoplanin | 63 | 1 | Vancomycin | 20 | 3 | 3 | |||
Vancomycin | 222 | 1 | |||||||
Unacceptable | |||||||||
Ampicillin/Sulbactam | 9 | Amoxicillin/Clavulanic acid | 2 | ||||||
Ciprofloxacin | 28 | 1 | Ampicillin/Sulbactam | 2 | |||||
Clindamycin | 6 | Bacitracin | 1 | ||||||
Gentamicin | 1 | 1 | Cefazolin | 2 | |||||
Imipenem | 7 | Cefepime | 1 | ||||||
Levofloxacin | 23 | Cefoperazone | 1 | ||||||
Nitrofurantoin | 11 | Cefotaxime | 1 | ||||||
Norfloxacin | 9 | Cefoxitin | 1 | ||||||
Oxacillin | 2 | Ceftazidime | 1 | 1 | |||||
Streptomycin | 1 | Ceftriaxone | 4 | 1 | 1 | ||||
Tetracycline | 3 | 6 | 17 | Ciprofloxacin | 4 | 6 | 3 | ||
Tigecycline | 5 | Clindamycin | 9 | ||||||
Trimethoprim/Sulfamethoxa | 2 | 3 | Gentamicin | 5 | 1 | 2 | |||
Imipenem | 2 | 1 | |||||||
Levofloxacin | 3 | 1 | 1 | ||||||
Meropenem | 1 | ||||||||
Netilmicin | 1 | ||||||||
Oxacillin | 4 | ||||||||
Oxacillin (Cefoxitin) | 2 | ||||||||
Tetracycline | 1 | 8 | |||||||
Tigecycline | 1 | ||||||||
Trimethoprim/Sulfamethoxa | 1 | 1 |
Abbreviations: MIC, minimum inhibitory concentration; S, susceptible; I, intermediate; R, resistance; IND, indeterminate; CLSI, Clinical and Laboratory Standards Institute.